ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 131,41
0,69%
Dow Jones
39 080,52
0,50%
DAX
18 498,38
0,32%
Brent Oil
83,545
0,82%
Bitcoin
62 296,23
-0,06%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Foghorn Therapeutics Inc (FHTX)

  7. Foghorn Therapeutics Inc (FHTX) Actualités

FHTX Foghorn Therapeutics Inc

5,81
0,18 (3,20%)
Dernière mise à jour : 21:30:12
Retardé de 15 minutes
Nom Action Symbole Action Marché Type
Foghorn Therapeutics Inc FHTX NASDAQ Action ordinaire
  Variation Action Variation Action% Cours Dernier Dernier échange
Upgrade Icon
0,18 3,20% 5,81 21:30:12
Ouverture Plus Bas Plus Haut Prix de clôture Clôture Veille
5,51 5,51 5,88 5,63
plus d'informations sur les cotations »

Actualités Recentes

Date Heure Source Titre
06/5/202422:54EDGAR2Form 8-K - Current report
06/5/202413:03EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
06/5/202413:03EDGAR2Form S-8 - Securities to be offered to employees in employee..
06/5/202413:03EDGAR2Form 8-K - Current report
07/3/202413:11EDGAR2Form 8-K - Current report
07/3/202413:09EDGAR2Form 10-K - Annual report [Section 13 and 15(d), not S-K..
08/2/202413:04EDGAR2Form 8-K - Current report
25/1/202422:05EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:02EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/1/202422:01EDGAR2Form 4 - Statement of changes in beneficial ownership of..
17/1/202422:09EDGAR2Form 8-K - Current report
08/1/202413:04EDGAR2Form 8-K - Current report
03/1/202422:18EDGAR2Form 8-K - Current report
28/11/202301:01PRNUSFlagship Pioneering Marks Official Opening of UK Hub with..
21/11/202312:00PRNUSFlagship Pioneering Unveils Quotient Therapeutics to Create..
02/11/202312:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
02/11/202312:03EDGAR2Form 8-K - Current report
01/11/202315:30PRNUSFlagship Pioneering Launches Pioneering Intelligence
11/9/202312:30PRNUSFlagship Pioneering Announces Appointment of Amanda Kay as..
08/9/202313:04EDGAR2Form 8-K - Current report
05/9/202314:00GLOBEFoghorn Therapeutics Announces Participation in Upcoming..
31/8/202313:04EDGAR2Form 8-K - Current report
31/8/202313:00GLOBEFoghorn Therapeutics Announces First Patient Dosed in Phase..
29/8/202315:00PRNUSInvaio achieves first registration for citrus greening..
18/8/202322:03EDGAR2Form 4 - Statement of changes in beneficial ownership of..
10/8/202322:08EDGAR2Form 8-K - Current report
08/8/202313:05EDGAR2Form 8-K - Current report
08/8/202313:00GLOBEFoghorn Therapeutics Announces Chief Medical Officer..
04/8/202313:08EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
04/8/202313:05EDGAR2Form 8-K - Current report
04/8/202313:00GLOBEFoghorn Therapeutics Provides Second Quarter 2023 Financial..
28/6/202313:00GLOBEFoghorn Therapeutics Announces Clinical Data from Phase 1..
05/6/202314:07DJNFoghorn Therapeutics Shares Rally Premarket as FDA Lifts..
16/5/202312:00PRNUSFlagship Pioneering Launches Metaphore Biotechnologies to..

Dernières Valeurs Consultées

NASDAQ
FHTX
Foghorn Therapeutics
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés